Clinical trials - Press Releases

Date	Title	Company
08-Dec-2020	Partnership for the supply and production of the Sputnik V vaccine in Ukraine discussed at a meeting between Kirill Dmitriev, Alexander Gintsburg and Victor Medvedchuk	Russian Direct Investment Fund
08-Dec-2020	RetinAI Announces Collaboration with Novartis to Provide Artificial Intelligence Solutions in Ophthalmology	RetinAI Medical AG
08-Dec-2020	Pioneering COVID-19 Test Detects Virus with Smartphone	Two-Photon Research Inc
07-Dec-2020	YESCARTA® (AXICABTAGENE CILOLEUCEL) IS FIRST CAR T CELL THERAPY TO DEMONSTRATE HIGH RESPONSE RATES AND DURABLE CLINICAL BENEFIT IN A PIVOTAL INDOLENT NON-HODGKIN LYMPHOMA STUDY	Kite, a Gilead Company
07-Dec-2020	Nokia and Vi CSR deploy SmartAgri solution to enhance farming practices of 50,000 farmers	Nokia and Vodafone India Foundation
07-Dec-2020	Medigene AG: Detailed analysis from Medigene's completed Phase I/II DC vaccine in AML patients presented orally at ASH 2020	Medigene
07-Dec-2020	Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer	Transgene
07-Dec-2020	Stress and anxiety levels increasing in NHS staff during COVID-19	Nuance
07-Dec-2020	Moberg Pharma publishes prospectus relating to the rights issue	Moberg Pharma AB
07-Dec-2020	Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets	Kaia Health
07-Dec-2020	Biophytis –Upcoming Potential Value Generating Milestones	Biophytis SA
06-Dec-2020	MAGROLIMAB DEMONSTRATES CLINICAL RESPONSES IN ONGOING PHASE 1B TRIAL OF PREVIOUSLY UNTREATED ACUTE MYELOID LEUKAEMIA PATIENTS	Gilead Sciences, Inc.
06-Dec-2020	NEW FOUR-YEAR DATA SHOW LONG-TERM SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA TREATED WITH YESCARTA® (AXICABTAGENE CILOLEUCEL) IN ZUMA-1 TRIAL	Kite, A Gilead Company
06-Dec-2020	YESCARTA® (AXICABTAGENE CILOLEUCEL) IS FIRST CAR T CELL THERAPY TO DEMONSTRATE HIGH RESPONSE RATES AND DURABLE CLINICAL BENEFIT IN A PIVOTAL INDOLENT NON-HODGKIN LYMPHOMA STUDY	Kite, A Gilead Company
02-Dec-2020	UK biotech company ILC Therapeutics announces first international investment	ILC Therapeutics
02-Dec-2020	Kallik becomes first artwork and labelling management software company to offer customers the security of Amazon Web Services	Kallik
02-Dec-2020	John Bell & Croyden expands same day coronavirus testing service with launch of new 15-minute point-of-care test	John Bell & Croyden
02-Dec-2020	Actimed Therapeutics Granted Broad US Patent Covering Rights to ACM–002 (S-oxprenolol) for Treating Cancer Cachexia	Actimed Therapeutics
02-Dec-2020	Helsinn and Kyowa Kirin Asia Pacific sign exclusive license and distribution agreement to strengthen their presence in Asia Pacific’s rare disease therapy area	Helsinn Group
02-Dec-2020	Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio	Sosei Group Corporation